High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.

@article{Preisler1986HighdoseCA,
  title={High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.},
  author={Harvey D. Preisler and Azra Raza and Maurice Barcos and Nozar Azarnia and R. Larson and George Browman and Irwin Walker and Hans Grunwald and Peter D'Arrigo and Anat Stein},
  journal={American journal of hematology},
  year={1986},
  volume={23 2},
  pages={131-4}
}
Fifteen patients with myelodysplastic/myeloproliferative disorders were treated with high-dose cytosine arabinoside therapy. While severe toxicity was produced in every patient, only two of the 15 patients entered complete remission and two achieved partial remission status. The therapeutic responses were confined to patients who had severe myelofibrosis of apparently recent onset. 

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
13 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 13 extracted citations

Myelodysplastic syndrome.

  • Shinji Nakao, H Joachim Deeg, Takayuki Ishikawa, Judith Marsh, Alan List, Masao Tomonaga
  • International journal of hematology
  • 2005

Similar Papers

Loading similar papers…